Latest News

Phase 1/2 trial of ONCT-534 in mCRPC has been terminated
Phase 1/2 trial of ONCT-534 in mCRPC has been terminated

November 7th 2024

The decision was based on an interim readout from the trial, which showed that ONCT-534 did not lead to any clinically meaningful improvement of disease.

Phase 3 ENLIGHTED trial: Padeliporfin VTP shows promise in low-grade UTUC
Phase 3 ENLIGHTED trial: Padeliporfin VTP shows promise in low-grade UTUC

November 7th 2024

Genomic risk model validated for prostate cancer risk prediction
Genomic risk model validated for prostate cancer risk prediction

November 6th 2024

Study to assess performance of CxBladder test in urothelial carcinoma surveillance
Study to assess performance of CxBladder test in urothelial carcinoma surveillance

November 6th 2024

Electronic smart checklist and document on virtual screens concept | Image Credit: © NongAsimo
Money Matters: Go into 2025 strong with this year-end financial checklist

November 6th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.